-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Apogee Therapeutics, Raises Price Target to $135

Benzinga·08/13/2026 15:46:24
Listen to the news
Truist Securities analyst Danielle Brill maintains Apogee Therapeutics (NASDAQ:APGE) with a Hold and raises the price target from $81 to $135.